DALLAS, February 6, 2013 /PRNewswire/ -- The "Brain Monitoring Marketby Product [EEG/Magnetoencephalography (MEG)/Intracranial Pressure Monitor/Cerebral Oximeter/Transcranial Doppler] & Application [Sleep Disorders/Epilepsy/Traumatic Brain Injury/ Brain Death] - Global Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and Rest of the World (RoW). Browse 132market data tables and16figuresspread through313 pages andin-depth TOC on Brain Monitoring Market by Product [EEG/Magnetoencephalography (MEG)/Intracranial Pressure Monitor/Cerebral Oximeter/Transcranial Doppler] & Application [Sleep Disorders/Epilepsy/Traumatic Brain Injury/ Brain Death] - Global Forecasts to 2017http://www.marketsandmarkets.com/Market-Reports/brain-monitoring-devices-market-909.htmlEarly buyers will receive 10% customization on reports. This report studies the global brain monitoring devices market, with forecast to 2017. Brain monitoring devices measure the activities of small waves produced by the brain. Multimodal monitoring of brain function is a growing area in the preoperative setting. Adverse cerebral outcome is a persistent problem in patients undergoing a variety of surgical procedures, which makes brain monitoring an important aspect for such clinical events. The global brain monitoring devices market was valued at $1.08 billion in 2012, and is poised to grow at a CAGR of 8.6% to reach $1.63 billion by 2017. The global brain monitoring devices market is broadly segmented into three categories based on its product, application, and end-user. It is witnessing various technological advancements leading to high functionality, lower costs, ease of operation, and miniaturization of devices fuelling the growth of this market. In the past, brain monitoring was not given much importance during routine checkups, preoperative and post-operative periods, and in critical care settings. However, this scenario is changing, with brain monitoring now being widely practiced to assess the depths of anesthesia and sedation. It is being used in a variety of clinical settings, which include operating rooms, intensive care units, and ambulatory units, which, in turn, will fuel demand for brain monitoring devices such as EEG, ICP, and cerebral oximeters in the coming years.